OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.65
+3.67%Leverage
- Debt / equity
- 2.41x
- Net debt / equity
- 1.71x
- Debt / assets
- 0.61x
- Debt / EBITDA
- -1.24x
- Net debt / EBITDA
- -0.88x
Liquidity & coverage
- Current ratio
- 8.26x
- Quick ratio
- 8.24x
- Cash ratio
- 8.16x
- Interest coverage
- -27.63x
- EBITDA / interest
- -27.20x
- Working capital
- $97.8M
Cash & dividend
- FCF / debt
- -0.84x
- Cash flow / debt
- -0.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026